Artemyeva, A. V.

Issue Section Title Abstract File
Vol 95, No 2 (2019) SCIENTTIFIC RESEARCHES Netakimab — new IL-17а inhibitor: 12-week results of phase III clinical study BCD-085-7/PLANETA in patients with moderate-tosevere plaque psoriasis Abstract PDF
(Rus)
Vol 95, No 3 (2019) DRUG TREATMENT IN DERMATOVENEROLOGY Long-term efficacy and safety of netakimab in patients with moderate-to-severe psoriasis. Results of phase II open-label extension clinical study BCD-085-2-ext Abstract PDF
(Rus)

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies